Opiant Pharmaceuticals Total Liabilities

Opiant Pharmaceuticals (OPNT) currently reports a total liabilities of $21M as of September 2022. That compares with $27M in the prior-year period — down 20.5% year over year. Use the charts on this page to explore Opiant Pharmaceuticals's total liabilities history and peer comparisons.

Opiant Pharmaceuticals's total liabilities decreased from $27M to $21M — a 20.5% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opiant Pharmaceuticals reported $21M in total liabilities as of September 2022. That compares with $27M in the prior-year period — down 20.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Opiant Pharmaceuticals, and consider following OPNT for alerts when major investors trade the stock.

Opiant Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPNT with unrelated industries.